Open access
Clinical Characterization of Invasive Meningococcal Disease Epidemic, Uzbekistan, 2026
B. Rakhimov
L. Tuychiev
Nilufar T. Khamzayeva
Nigora U. Tadjiyeva
Nargiza S. Saidkasimova
Nargiza X. Otamuratova
Xolmamat N. Norboev
Medicine
Abstract
Tashkent, Uzbekistan, registered 290 invasive meningococcal disease cases during January–April 2026; the case fatality rate was 8.3%. Meningeal signs appeared in only 3.1% of patients and were the sole signs associated with death. Neisseria meningitidis serogroup surveillance and conjugate vaccine introduction will be needed to prevent invasive meningococcal disease in Uzbekistan.